(19)
(11) EP 0 837 864 A1

(12)

(43) Date of publication:
29.04.1998 Bulletin 1998/18

(21) Application number: 96924829.0

(22) Date of filing: 01.07.1996
(51) International Patent Classification (IPC): 
A61K 31/ 675( . )
A61P 9/ 10( . )
C07D 241/ 44( . )
A61P 9/ 00( . )
A61P 25/ 08( . )
C07F 9/ 6509( . )
(86) International application number:
PCT/EP1996/002866
(87) International publication number:
WO 1997/003079 (30.01.1997 Gazette 1997/06)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
SI

(30) Priority: 10.07.1995 CH 19950002009

(71) Applicant: Novartis AG
4058 Basel (CH)

(72) Inventors:
  • MORETTI, Robert
    CH-1627 Vaulruz (CH)
  • ALLGEIER, Hans
    D-79541 Lörrach (DE)

(74) Representative: Roth, Bernhard M., et al 
Novartis AG Geistiges Eigentum Konzern
4002 Basel
4002 Basel (CH)

   


(54) NOVEL QUINOXALINE- AND QUINOXALINYLALKANE-PHOSPHONIC ACIDS